MedAssets (MDAS) Tops Q2 EPS by 4c; Guides FY15 EPS Above Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
KeyBanc Downgrades MedAssets (MDAS) to Sector Weight
July 31, 2015 7:29 AM EDTKeyBanc downgraded MedAssets (NASDAQ: MDAS) from Overweight to Sector Weight.
Analyst Donald Hooker said, "We are downgrading MedAssets, Inc. (MDAS) to Sector Weight on the recent share price increase (last 6 months: up 26% vs. S&P up 5%). We think the shares are getting a healthy... More
Leerink Raises Price Target on MedAssets (MDAS) Following 2Q EPS Beat
July 30, 2015 10:32 AM EDTLeerink Partners reiterated a Market Perform rating on MedAssets (NASDAQ: MDAS), and raised the price target to $22.00 (from $21.00), following 2Q15 results. MDAS reported 2Q total revenue of $190.4M, ahead consensus of $187.3M. Adjusted EPS of $0.31 was also ahead of consensus of $0.27.
Analyst David Larsen commented, "This afternoon... More
